Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis.
The potent antimalarial drug pyronaridine (PND) was tested for its potential as an anticancer drug. After exposing cancerous (17) and non-cancerous (2) cells to PND for 72 hr, PND was found to exhibit consistent and potent cytotoxic activity at low micromolar (μM) concentrations that ranged from 1.6...
Main Authors: | Paulina J Villanueva, Alberto Martinez, Sarah T Baca, Rebecca E DeJesus, Manuel Larragoity, Lisett Contreras, Denisse A Gutierrez, Armando Varela-Ramirez, Renato J Aguilera |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6218039?pdf=render |
Similar Items
-
Population pharmacokinetics and pharmacodynamics of pyronaridine
by: Methaneethorn, Janthima
Published: (2013) -
Population pharmacokinetics of pyronaridine in the treatment of malaria
by: Wattanavijitkul, Thitima
Published: (2010) -
Pharmacokinetics of pyronaridine in adult and pediatric populations
by: Ayyoub, Amal Suleiman
Published: (2016) -
Review of pyronaridine anti-malarial properties and product characteristics
by: Croft Simon L, et al.
Published: (2012-08-01) -
A study of the antimalarial action of Pyronaridine and its accumulation into Plasmodium falciparum
by: Mtegha, Chikumbusko J
Published: (2014)